Author Question: The federal government incentive to support special-interest groups (steel, auto, drug, environment) ... (Read 95 times)

cabate

  • Hero Member
  • *****
  • Posts: 537
The federal government incentive to support special-interest groups (steel, auto, drug, environment) at the expense of unorganized, widely dispersed groups (for example, taxpayers or consumers) occurs
 
  (a) only when the benefits that accrue to the special-interest group exceed the costs
  imposed on others.
  (b) when nonspecial-interest voters are unconcerned or uninformed about the issue, and
  campaign funds are readily available from the special-interest group.
  (c) only if the government action is efficient.
  (d) only if the government action will reduce the monopoly power of business or labor,
  and thereby lead to an improvement in the general welfare.

Question 2

From 1860 to 1910, international net capital flow into the U.S.
 
  (a) was positive when the U.S. economy expanded.
  (b) was neutral and not influenced by the U.S. business cycle.
  (c) was negative when the U.S. economy grew.
  (d) was positively impacted by U.S. discussions about and actual restrictions
  on immigration.



dajones82

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

(b)

Answer to Question 2

(a)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library